Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 6, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	274,264	297,962	170,528	81,683	-	-
Market Cap Growth	74.73%	74.73%	108.77%	-	-	-
Enterprise Value	317,618	341,742	209,922	130,128	-	-
Last Close Price	206.33	224.75	128.81	66.80	-	-
PE Ratio	300.96	326.96	956.95	-	-	-
Forward PE	144.17	70.54	42.33	40.39	-	-
PS Ratio	3.00	3.26	2.09	1.15	-	-
PB Ratio	3.38	3.67	2.15	1.21	-	-
P/TBV Ratio	6.79	7.38	4.71	3.51	-	-
P/FCF Ratio	120.33	130.73	58.30	-	-	-
P/OCF Ratio	30.74	33.39	16.98	16.88	-	-
PEG Ratio	1.58	1.58	1.58	1.35	-	-
EV/Sales Ratio	3.47	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	20.93	24.34	18.43	22.58	-	-
EV/EBIT Ratio	45.28	54.38	45.62	-	-	-
EV/FCF Ratio	139.36	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.36	3.36	4.00	9.21	3.63	2.30
Debt / FCF Ratio	21.31	21.31	16.10	-	-	-
Asset Turnover	0.59	0.59	0.55	0.52	0.57	-
Inventory Turnover	1.44	1.44	1.69	1.94	1.87	-
Quick Ratio	0.76	0.76	0.61	0.64	0.69	0.82
Current Ratio	1.54	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	1.14%	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	2.54%	2.54%	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	3.07%	3.07%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	5.30%	5.30%	4.20%	-	5.70%	10.50%
Earnings Yield	0.33%	0.31%	0.10%	-2.28%	-	-
FCF Yield	0.83%	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.07%	0.06%	0.08%	-	-	-
Payout Ratio	15.88%	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	-4.41%	-4.41%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-4.35%	-4.35%	-7.76%	-0.95%	-87.83%	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.